Article

EnVision Summit 2023: The challenges of tube shunts for glaucoma in pediatric eyes

Author(s):

During a presentation at the EnVision Summit Ophthalmology 2023 at El Conquistador Resort in Puerto Rico, Elena Bitrian, MD, outlines the challenges that surgeons are confronted with surgically in pediatric eyes, including the limited working space and palpebral fissure, axial length, and avoidance of the thin sclera and shallow scleral pass.

The challenges that surgeons are confronted with surgically in these eyes are the limited working space and palpebral fissure, axial length, and avoidance of the thin sclera and shallow scleral pass. (Image courtesy stock.adobe.com)

The challenges that surgeons are confronted with surgically in these eyes are the limited working space and palpebral fissure, axial length, and avoidance of the thin sclera and shallow scleral pass. (Image courtesy stock.adobe.com)

Performing glaucoma surgery on pediatric patients is very different from addressing the disease surgically in adults, according to Elena Bitrian, MD, who discussed the topic at the EnVision Summit Ophthalmology 2023 at El Conquistador Resort in Puerto Rico and shared her pearls.

Bitrian is associate professor of Ophthalmology, Director of Education, Balkan International Pediatric Glaucoma Center, Bascom Palmer Eye Institute, Miami.

The challenges that surgeons are confronted with surgically in these eyes are the limited working space and palpebral fissure, axial length, and avoidance of the thin sclera and shallow scleral pass. Surgeons must also plan for ocular growth and the potential for occlusion after cataract surgery, she pointed out.

When the decision to perform shunt surgery has been made, the surgeons then face a number of preoperative considerations: the choice of tube type, ie, valved (Ahmed Glaucoma Valve, New World Medical) or non-valved (Baerveldt Glaucoma Implant, Johnson & Johnson Surgical Vision, Inc.; Ahmed Clearpath, New World Medical), surgical site, ie, superotemporal or inferonasal, and look for scarring or thinning; and finally, the conjunctival incision, a limbus-based conjunctival flap for aniridia and contact lens

Special cases

There are special cases among this patient population that require additional focus.

In pediatric patients with Sturge Weber syndrome, Bitrian advised surgeons to avoid a rapid decrease in intraocular pressure, use of Healon, and an anterior chamber maintainer and avoidance of fenestrations, intraluminal stents, and staged procedures.

In patients with aniridia, a limbal-based conjunctival incision is required and the surgeon should avoid touching the lens.

The presence of uveitis requires that hypotony be avoided because of poor ciliary body function, as well as valved devices and intraluminal stents.

The last special consideration is cataract surgery. Bitrian advised that the tube be positioned in the sulcus or pars plana to both protect the cornea and prevent tubal erosions. In this scenario, there is a risk of tubal occlusion and the tube should be left long to facilitate direct visualization.

In cases needing a second shunt placement, Bitrian advised that the shunt be located inferonasally. Use of a second shut carries the risk of corneal failure and exposure. In addition, the question arises about implanting the same glaucoma device or a different one. The development of diplopia is another factor to be considered in patients receiving a second shunt.

The complications associated with shunt implantation include pupillary irregularities, lenticular opacification, extrusion, strabismus, tubal migration, and tube cornea touch.

Pearls

Bitrian’s suggestions for successful tube shunt surgeries in children include use of a limbus-based approach, which she considers to be superior; a sclerostomy track parallel to the limbus in the periphery; leave long tubes especially in infants; strong closure of Tenon’s and the conjunctiva; careful monitoring of patients for need of tube positioning; and early resolution of complications.

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
AAO 2024: Weijie Violet Lin, MD, discusses risk factors for epithelium-off cross-linking
© 2024 MJH Life Sciences

All rights reserved.